Clinical Trial Update: Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin, paclitaxel, and everolimus in patients with previously untreated carcinoma of unknown primary. The study status is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma of Unknown Primary

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Everolimus (everolimus)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Carcinoma of Unknown Primary Origin | Phase 2 | Status: COMPLETED | Results posted: 2017-02-16